Recro Pharma logo
Recro Pharma REPH
$ 1.4 -4.76%

Annual report 2023
added 03-22-2024

report update icon

Recro Pharma ROE Ratio 2011-2024 | REPH

Annual ROE Ratio Recro Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-22.63 -33.21 -27.03 195.04 277.56 408.84 -173.6 -42.18 7.52 -85.24 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
408.84 -173.6 50.51

Quarterly ROE Ratio Recro Pharma

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-31.61 -33.18 -35.62 -28.69 -36.53 -34.92 -21.89 74.33 89.42 112.34 150.31 112.28 176.42 225.47 225.08 135.86 203.84 207.68 230.62 197.06 165.67 66.3 -29.59 -90.12 -97.63 -73.75 -54.07 -27.65 -32.99 -30.81 -23.05 -18.83 -43.73 -63.3 -74.81 -66.85 -64.04 -36.34 -17.89 8.76 8.76 5.96 2.28 - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
230.62 -97.63 30.94